Michael D. Ober

Michael D. Ober

Auto-generated profile, based on publicly available information

Michael D. Ober

Retina Consultants of Michigan, Southfield, Michigan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
LSLindsay M. Smithen
Lindsay M. Smithen
MOMichael D. Ober
Michael D. Ober
LMLeandro Maranan
Leandro Maranan
RSRichard F. Spaide
Richard F. Spaide

1 October 2011 in Archives of Ophthalmology (1950)
Verified
Journal Article
Closed access
PDF file
RMRon Margolis
Ron Margolis
SMSri Krishna Mukkamala
Sri Krishna Mukkamala
LJLee M. Jampol
Lee M. Jampol
RSRichard F. Spaide
Richard F. Spaide
MOMichael D. Ober
Michael D. Ober
KFK. Bailey Freund
K. Bailey Freund
Research from JAMA Ophthalmology — The Expanded Spectrum of Focal Choroidal Excavation

1 March 2004 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
LYLawrence A. Yannuzzi
Lawrence A. Yannuzzi
MOMichael D. Ober
Michael D. Ober
JSJason S. Slakter
Jason S. Slakter
RSRichard F. Spaide
Richard F. Spaide
YFYale L. Fisher
Yale L. Fisher
RRRichard Rosen
Richard Rosen

1 October 2005 in Retina
Verified
Journal Article
Closed access
OÇOsman Çeki̇ç
Osman Çeki̇ç
SCStanley Chang
Stanley Chang
JTJoseph J. Tseng
Joseph J. Tseng
GBGaetano R. Barile
Gaetano R. Barile
LPLucian V. DEL Priore
Lucian V. DEL Priore
MOMichael D. Ober
Michael D. Ober
To evaluate the efficacy of intravitreal triamcinolone injection in eyes with macular edema due to branch retinal vein occlusion (BRVO) over a 2-year period. The authors performed a retrospective chart review of 13 eyes of 13 patients (mean age 68 years) who underwent intravitreal injections with 4 mg triamcinolone acetonide for macular edema due to BRVO. Six eyes received a single injection. Repeated injections were performed in one eye twice, four eyes three times, and two eyes four times. Mean follow-up was 13 months (range, 4 to 24). The time between the onset of symptoms and the injection averaged 7.4 months (range, 2 to 24). Mean postinjection central foveal thickness decreased to 56% of preinjection values (529 μm versus 295 μm, P < 0 .001). Final visual acuity improved in seven eyes (range 2 to 6 Snellen lines), remained the same in four eyes (range 0 to 1 Snellen lines), and worsened in two eyes (range −1 to −4 Snellen lines) compared to baseline. The retinal thickness decreased in all cases; vision improved in most cases. As the number of injections increased cataractous changes increased. Visual acuity improvement was significantly correlated with patient age (P = 0.026). Eight patients developed steroid induced ocular hypertension controlled by topical medication. Cataract extraction was judged to aggravate macular edema in three of the five eyes undergoing surgery, based upon optical coherence tomography or fluorescein angiography. Median best postinjection visual acuity (20/50) was significantly better than that of baseline (20/100) (P = 0.028) as well as last follow-up (20/70) (P = 0.003). Intravitreal triamcinolone should be further evaluated as a treatment option for macular edema associated with BRVO.

1 December 2005 in Ophthalmology
Verified
Journal Article
Closed access
MOMichael D. Ober
Michael D. Ober
LYLawrence A. Yannuzzi
Lawrence A. Yannuzzi
DDDiana V. Do
Diana V. Do
RSRichard F. Spaide
Richard F. Spaide
NBNeil M. Bressler
Neil M. Bressler
ALAlice T. Lyon
Alice T. Lyon

1 December 2005 in Retina
Verified
Journal Article
Closed access
CEChiara Maria Eandi
Chiara Maria Eandi
MOMichael Ober
Michael Ober
RIReza Iranmanesh
Reza Iranmanesh
EPEnrico Peiretti
Enrico Peiretti
LYLawrence A. Yannuzzi
Lawrence A. Yannuzzi
To describe fundus autofluorescence (FAF) in a series of patients with acute central serous chorioretinopathy (CSC). Nine eyes of six patients with acute CSC were evaluated with fluorescein angiography (FA) and FAF imaging to evaluate the nature of the focal retinal pigment epithelial (RPE) leak evident with FA. All nine eyes in this series demonstrated hypoautofluorescence corresponding precisely to the site of the focal RPE leak seen on FA. In this group of patients, the acute focal RPE leaks seen with FA corresponded precisely to an area of hypoautofluorescence imaged with FAF. This observation supports the concept that a mechanical defect or absence of the RPE accounts for the leakage from the inner choroid to the subneurosensory space in CSC. FAF is also a useful noninvasive diagnostic adjunct to identify the focal RPE leak in patients with acute CSC.